| Primary |
| Computerised Tomogram |
48.1% |
| Premedication |
9.8% |
| Angiogram |
6.5% |
| Computerised Tomogram Abdomen |
6.5% |
| Product Used For Unknown Indication |
5.1% |
| Arteriogram Coronary |
3.3% |
| Computerised Tomogram Head |
2.8% |
| Urogram |
2.6% |
| Liver Disorder |
2.1% |
| Computerised Tomogram Thorax |
1.6% |
| Arthrogram |
1.4% |
| Constipation |
1.4% |
| Hypertension |
1.4% |
| X-ray |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Diarrhoea |
1.2% |
| Cerebral Artery Occlusion |
0.9% |
| Chemotherapy |
0.9% |
| Diabetes Mellitus |
0.9% |
| Scan With Contrast |
0.9% |
|
| Anaphylactic Shock |
14.2% |
| Urticaria |
9.0% |
| Dyspnoea |
8.5% |
| Rash |
7.5% |
| Pruritus |
6.1% |
| Shock |
6.1% |
| Hypersensitivity |
5.2% |
| Nephropathy Toxic |
5.2% |
| Cough |
4.2% |
| Throat Tightness |
4.2% |
| Anaphylactic Reaction |
3.8% |
| Loss Of Consciousness |
3.8% |
| Sneezing |
3.8% |
| Wheezing |
3.3% |
| Throat Irritation |
2.8% |
| Tremor |
2.8% |
| Chest Discomfort |
2.4% |
| Injury |
2.4% |
| Oxygen Saturation Decreased |
2.4% |
| Respiratory Arrest |
2.4% |
|
| Secondary |
| Computerised Tomogram |
46.7% |
| Hypertension |
10.0% |
| Cardiac Failure |
8.3% |
| Angiogram |
6.7% |
| Cerebral Artery Occlusion |
6.7% |
| Arthrogram |
5.0% |
| Carotid Artery Stent Insertion |
5.0% |
| Ill-defined Disorder |
5.0% |
| Aortic Aneurysm |
1.7% |
| Haemorrhagic Stroke |
1.7% |
| Mediastinal Disorder |
1.7% |
| Product Used For Unknown Indication |
1.7% |
|
| Cerebral Haematoma |
12.5% |
| Pneumonia |
12.5% |
| Emotional Distress |
9.4% |
| Procedural Hypotension |
9.4% |
| Renal Failure |
9.4% |
| Swollen Tongue |
9.4% |
| Rash Erythematous |
6.3% |
| Blood Creatinine Increased |
3.1% |
| Dehydration |
3.1% |
| Hypersensitivity |
3.1% |
| Incorrect Route Of Drug Administration |
3.1% |
| Injection Site Necrosis |
3.1% |
| International Normalised Ratio Increased |
3.1% |
| Nuclear Magnetic Resonance Imaging Abnormal |
3.1% |
| Sneezing |
3.1% |
| Urticaria |
3.1% |
| Venous Thrombosis Limb |
3.1% |
|
| Concomitant |
| Hepatic Neoplasm Malignant |
8.6% |
| Diabetes Mellitus |
8.5% |
| Nephrotic Syndrome |
6.8% |
| Abdominal Distension |
5.5% |
| Arthralgia |
5.5% |
| Product Used For Unknown Indication |
5.1% |
| Constipation Prophylaxis |
4.9% |
| Decreased Appetite |
4.9% |
| Drug Use For Unknown Indication |
4.9% |
| Excoriation |
4.9% |
| Hepatitis B |
4.9% |
| Mydriasis |
4.9% |
| Stomatitis |
4.9% |
| Vomiting |
4.9% |
| Gastrointestinal Disorder |
4.2% |
| Computerised Tomogram |
3.8% |
| Hypertension |
3.8% |
| Prophylaxis |
3.8% |
| Nuclear Magnetic Resonance Imaging |
2.5% |
| Parenteral Nutrition |
2.5% |
|
| Arthralgia |
24.0% |
| Nephrotic Syndrome |
22.0% |
| Injury |
14.0% |
| Retinal Vascular Thrombosis |
8.0% |
| Rash Maculo-papular |
6.0% |
| Unevaluable Event |
6.0% |
| Anxiety |
4.0% |
| Renal Impairment |
4.0% |
| Anhedonia |
2.0% |
| Drug Level Increased |
2.0% |
| Fear |
2.0% |
| Off Label Use |
2.0% |
| Rash |
2.0% |
| Vomiting |
2.0% |
|
